Replicate Design [General Sta­tis­tics]

posted by ratnakar1811 – India, 2008-09-01 10:53 (5935 d 10:53 ago) – Posting: # 2292
Views: 8,276

Dear Forum Members,

Can anybody tell about the consideration of data of subjects for statistical analysis in a replicate design study (i.e. 4 period, 2 treatment, 2 sequence), whether we can consider the subjects who have not completed all four period (i.e. subjects completed 3 period, 2 or only 1 period of the study) or we have to consider subject who have completed all 4 periods of the study and what are the statistical implications and at the same time acceptance by regulatory bodies.


Thanking you in advance.

Ratnakar Jadhav

Complete thread:

UA Flag
Activity
 Admin contact
23,328 posts in 4,898 threads, 1,661 registered users;
88 visitors (0 registered, 88 guests [including 9 identified bots]).
Forum time: 20:46 CET (Europe/Vienna)

Satisfaction of one’s curiosity is one of the greatest sources
of happiness in life.    Linus Pauling

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5